PLANT GENETICS INTERNATIONAL LIMITED


Silverfin false false 31/12/2023 01/01/2023 31/12/2023 Mrs C Bourne 10/10/2023 17/04/2015 Mr E Bourne 10/10/2023 17/04/2015 Mr D Langmead 15/12/2023 24/03/2015 Mr E Marley 24/03/2015 Mrs F Marley 24/03/2015 18 April 2024 The principal activity of the Company during the financial year was acquisition and creation of intellectual property. 09506669 2023-12-31 09506669 bus:Director1 2023-12-31 09506669 bus:Director2 2023-12-31 09506669 bus:Director3 2023-12-31 09506669 bus:Director4 2023-12-31 09506669 bus:Director5 2023-12-31 09506669 2022-12-31 09506669 core:CurrentFinancialInstruments 2023-12-31 09506669 core:CurrentFinancialInstruments 2022-12-31 09506669 core:Non-currentFinancialInstruments 2023-12-31 09506669 core:Non-currentFinancialInstruments 2022-12-31 09506669 core:ShareCapital 2023-12-31 09506669 core:ShareCapital 2022-12-31 09506669 core:SharePremium 2023-12-31 09506669 core:SharePremium 2022-12-31 09506669 core:OtherCapitalReserve 2023-12-31 09506669 core:OtherCapitalReserve 2022-12-31 09506669 core:RetainedEarningsAccumulatedLosses 2023-12-31 09506669 core:RetainedEarningsAccumulatedLosses 2022-12-31 09506669 core:OtherResidualIntangibleAssets 2022-12-31 09506669 core:OtherResidualIntangibleAssets 2023-12-31 09506669 core:CostValuation 2022-12-31 09506669 core:DisposalsDecreaseInInvestments 2023-12-31 09506669 core:CostValuation 2023-12-31 09506669 bus:OrdinaryShareClass1 2023-12-31 09506669 2023-01-01 2023-12-31 09506669 bus:FilletedAccounts 2023-01-01 2023-12-31 09506669 bus:SmallEntities 2023-01-01 2023-12-31 09506669 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 09506669 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 09506669 bus:Director1 2023-01-01 2023-12-31 09506669 bus:Director2 2023-01-01 2023-12-31 09506669 bus:Director3 2023-01-01 2023-12-31 09506669 bus:Director4 2023-01-01 2023-12-31 09506669 bus:Director5 2023-01-01 2023-12-31 09506669 core:OtherResidualIntangibleAssets core:TopRangeValue 2023-01-01 2023-12-31 09506669 2022-01-01 2022-12-31 09506669 core:OtherResidualIntangibleAssets 2023-01-01 2023-12-31 09506669 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 09506669 bus:OrdinaryShareClass1 2022-01-01 2022-12-31 09506669 bus:OrdinaryShareClass2 2023-01-01 2023-12-31 09506669 bus:OrdinaryShareClass2 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 09506669 (England and Wales)

PLANT GENETICS INTERNATIONAL LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2023
Pages for filing with the registrar

PLANT GENETICS INTERNATIONAL LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2023

Contents

PLANT GENETICS INTERNATIONAL LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2023
PLANT GENETICS INTERNATIONAL LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2023
DIRECTORS Mrs C Bourne (Resigned 10 October 2023)
Mr E Bourne (Resigned 10 October 2023)
Mr D Langmead (Resigned 15 December 2023)
Mr E Marley
Mrs F Marley
REGISTERED OFFICE Centenary House Peninsula Park
Rydon Lane
Exeter
EX2 7XE
United Kingdom
BUSINESS ADDRESS Ashcombe Road
Dawlish
Devon
EX7 0QP
COMPANY NUMBER 09506669 (England and Wales)
CHARTERED ACCOUNTANTS Francis Clark LLP
Centenary House
Peninsula Park
Rydon Lane
Exeter
Devon EX2 7XE
PLANT GENETICS INTERNATIONAL LIMITED

BALANCE SHEET

As at 31 December 2023
PLANT GENETICS INTERNATIONAL LIMITED

BALANCE SHEET (continued)

As at 31 December 2023
Note 2023 2022
£ £
Fixed assets
Intangible assets 3 55,000 110,000
Investments 4 105,193 467,403
160,193 577,403
Current assets
Debtors
- due within one year 5 95,417 246,283
- due after more than one year 5 0 40,000
Cash at bank and in hand 241,724 519,199
337,141 805,482
Creditors: amounts falling due within one year 6 ( 103,677) ( 331,665)
Net current assets 233,464 473,817
Total assets less current liabilities 393,657 1,051,220
Net assets 393,657 1,051,220
Capital and reserves
Called-up share capital 7 400 400
Share premium account 419,780 419,780
Other reserves 0 21,276
Profit and loss account ( 26,523 ) 609,764
Total shareholders' funds 393,657 1,051,220

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

  • The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
  • These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Plant Genetics International Limited (registered number: 09506669) were approved and authorised for issue by the Board of Directors on 18 April 2024. They were signed on its behalf by:

Mr E Marley
Director
PLANT GENETICS INTERNATIONAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
PLANT GENETICS INTERNATIONAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Plant Genetics International Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Centenary House Peninsula Park, Rydon Lane, Exeter, EX2 7XE, United Kingdom. The principal place of business is Ashcombe Road, Dawlish, Devon, EX7 0QP.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT, returns, rebates and trade discounts and after eliminating sales within the company. Turnover is recognised when the significant risks and rewards are considered to have been transferred to the buyer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Other intangible assets 10 years straight line
Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Investments

Investments in subsidiary undertakings are recognised at cost.

Other Reserves

The company has a long term loan which is classified as a financing arrangement. The difference between the initial consideration and the present value of future payments, discounted at a market rate of interest, has been credited to 'other reserves'. Amounts equivalent to the notional interest charge are transferred between reserves until the loans are repaid. The loan was paid off in the year.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 4 5

3. Intangible assets

Other intangible assets Total
£ £
Cost
At 01 January 2023 550,000 550,000
At 31 December 2023 550,000 550,000
Accumulated amortisation
At 01 January 2023 440,000 440,000
Charge for the financial year 55,000 55,000
At 31 December 2023 495,000 495,000
Net book value
At 31 December 2023 55,000 55,000
At 31 December 2022 110,000 110,000

4. Fixed asset investments

Investments in subsidiaries

2023
£
Cost
At 01 January 2023 467,403
Disposals ( 362,210)
At 31 December 2023 105,193
Carrying value at 31 December 2023 105,193
Carrying value at 31 December 2022 467,403

5. Debtors

2023 2022
£ £
Debtors: amounts falling due within one year
Trade debtors 93,836 204,474
Other debtors 1,581 41,809
95,417 246,283
Debtors: amounts falling due after more than one year
Amounts owed by Group undertakings 0 40,000

6. Creditors: amounts falling due within one year

2023 2022
£ £
Trade creditors 58,098 138,361
Amounts owed to Group undertakings 21,483 150,100
Accruals 2,500 1,475
Taxation and social security 21,596 41,729
103,677 331,665

7. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
400 Ordinary A shares of £ 1.00 each (2022: 380 shares of £ 1.00 each) 400 380
Nil Ordinary B shares (2022: 20 shares of £ 1.00 each) 0 20
400 400

The £1 Ordinary B Shares were reclassified to £1 Ordinary A Shares in the year.

8. Related party transactions

Other related party transactions

2023 2022
£ £
Amount owed by Valin Genetics Limited 0 40,000

Interest was charged on the loan at 10% which is considered a market rate of interest.